O’Melveny has advised Jiangxi Institute of Biological Products Inc. in connection with its listing on the Main Board of The Hong Kong Stock Exchange. Jiangxi Institute...
Jiangxi Institute of Biological Products Lists on Hong Kong Stock Exchange
TransThera Sciences Completes Placement of New H Shares Raising HK$152 Million
O’Melveny & Myers has advised TransThera Sciences (Nanjing), Inc. TransThera Sciences (Nanjing), Inc. has successfully placed 3,836,000 new H shares under a general mandate at a...
Time Interconnect Technology Completes HK$1.64 Billion Share Placement
O’Melveny & Myers has advised Macquarie in its role as overall coordinator, sole placing agent, and sole capital market intermediary for Time Interconnect Technology Limited. Time...



























